Overview The IgM Variable Major Protein E (VmpE) test detects early antibodies against a highly adaptable surface protein produced by Borrelia burgdorferi, the bacterium that causes Lyme disease. VmpE belongs to a family of variable major proteins (Vmps) that the bacteria switch on and off to escape immune detection, a process known as antigenic variation. Because of this constant shifting, VmpE is linked to Borrelia’s ability to persist and cause relapsing or chronic forms of infection. Understanding VmpE and the Immune Response Immune evasion: By rearranging its genes, Borrelia changes VmpE’s structure, escaping recognition by pre-existing antibodies. Role in persistence: This variation allows Borrelia to survive for long periods in the host, even after initial immune clearance. IgM recognition: Detecting IgM antibodies to VmpE indicates the immune system is actively responding to these variable proteins, usually in the early weeks of infection or in cases of ongoing immune activation. IgM Response to VmpE Appears within 1–3 weeks after a tick bite, often before IgG antibodies are detected. Effective in the early neutralization of infection but may persist when Borrelia continues producing new variants. Complements markers such as OspC and VlsE, broadening diagnostic insight into both early and persistent Lyme presentations. Clinical and Research Relevance Clinical use: May help support diagnosis in early Lyme disease, in suspected persistent infection, or when symptoms overlap with autoimmune-like conditions linked to chronic immune activation. Research value: Offers insight into how Borrelia uses antigenic variation to survive, why some patients may develop relapsing or chronic symptoms, and whether conserved VmpE regions might hold future vaccine potential. Limitations & Considerations Best early: IgM detection is most informative in the early weeks after infection. Caution later: Isolated IgM beyond 6–8 weeks may not indicate active infection. False positives: Cross-reactivity with other infections can occur. Confirmation needed: Other tests (IgG, VlsE/C6, multi-antigen panels) are often used alongside IgM VmpE for diagnostic accuracy. Summary The IgM VmpE test provides insight into the body’s early immune response against a variable protein used by Borrelia to escape detection and persist in the host. A positive result may suggest recent or ongoing infection, but interpretation requires clinical context, exposure history, and other supportive test results. If results are equivocal (borderline), antibody levels are near the cut-off and uncertain — this may indicate very early infection or a nonspecific immune reaction; repeat or confirmatory testing is usually recommended.
IL-1 beta refers to Interleukin-1 beta. Interleukin-1 beta is one of the cytokines assessed in the CytoDx Cytokine Response Profile offered by Diagnostic Solutions Laboratory. Cytokines are critical mediators of immune responses, and their imbalances have been linked to chronic inflammation and autoimmune diseases.
IL-10 (Interleukin-10) is a powerful anti-inflammatory cytokine that helps control immune overactivation and maintain immune tolerance. Produced by regulatory T cells (Tregs), monocytes, and macrophages, IL-10 suppresses excessive inflammatory signals and supports healing once an immune threat is cleared. Elevated IL-10 levels may indicate the body’s effort to calm chronic inflammation or infection, while low IL-10 often reflects poor immune regulation and a higher risk of autoimmune or inflammatory disorders. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-10 serves as a key marker of regulatory immune balance, helping clinicians assess whether inflammation is being effectively resolved or remains persistently active.
IL-13 (Interleukin-13) is an anti-inflammatory Th2 cytokine that regulates antibody production, tissue repair, and mucosal immunity. Produced by Th2 cells, mast cells, and ILC2s, IL-13 helps resolve inflammation but can also drive allergic and fibrotic responses when elevated. High IL-13 levels are linked to asthma, eczema, allergic rhinitis, and fibrotic diseases, indicating Th2 immune dominance. Low IL-13 may occur in autoimmune or Th1/Th17-driven inflammation, reflecting reduced regulatory control. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-13 serves as a marker of anti-inflammatory activity and immune balance, helping clinicians determine whether the immune system is effectively resolving inflammation or skewed toward chronic allergic or inflammatory stress.
IL-15 (Interleukin-15) is a pro-inflammatory cytokine that activates natural killer (NK) cells and CD8+ T cells, strengthening the body’s defense against infections and tumors. It also promotes interferon-gamma (IFN-γ) production, amplifying immune responses. Elevated IL-15 levels can indicate chronic inflammation, autoimmune activity, or persistent infection, and are often seen in conditions like rheumatoid arthritis, celiac disease, and inflammatory bowel disease. Low IL-15 may suggest reduced immune cell function or immune suppression. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-15 serves as a marker of Th1-driven immune activation, offering valuable insight into immune system stress and helping guide targeted approaches to restore immune balance and resilience.
IL-17A (Interleukin-17A) is a pro-inflammatory cytokine produced by Th17 cells that plays a key role in defending against bacterial and fungal infections. It promotes neutrophil recruitment and stimulates other inflammatory cytokines like IL-6 and TNF-α. Elevated IL-17A levels indicate Th17-dominant inflammation and are commonly seen in autoimmune diseases, psoriasis, IBD, and chronic inflammatory conditions. Chronically high IL-17A can drive tissue damage and immune dysregulation, while low IL-17A may signal weakened mucosal immunity or immune suppression. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-17A helps identify chronic inflammatory patterns and autoimmune activity, offering valuable guidance for restoring immune balance and reducing inflammation.
IL-18 (Interleukin-18) is a pro-inflammatory cytokine that activates Th1 and natural killer (NK) cells, driving the release of interferon-gamma (IFN-γ) and amplifying immune and inflammatory responses. While essential for fighting infections, persistently high IL-18 levels can promote chronic inflammation, autoimmune reactions, metabolic stress, and cardiovascular or neuroinflammatory disorders. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-18 serves as a key marker of Th1/Th17 pathway activity, helping identify immune system overactivation or imbalance. Elevated IL-18 often reflects ongoing inflammatory stress, whereas balanced levels indicate healthy immune communication and regulation.
IL-2 (Interleukin-2) is a pro-inflammatory Th1 cytokine that promotes the growth and activation of T cells, NK cells, and B cells, playing a key role in immune defense and regulation. Produced by activated T-helper cells, IL-2 strengthens immune responses while also supporting regulatory T cells (Tregs) to prevent autoimmunity. Elevated IL-2 levels often indicate immune activation, autoimmune activity, or chronic inflammation, whereas low IL-2 may reflect immune exhaustion, poor T-cell function, or regulatory imbalance. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-2 serves as a core marker of Th1 immune strength and balance, helping clinicians evaluate whether the immune system is properly activated, overactive, or suppressed.
IL-4 (Interleukin-4) is an anti-inflammatory cytokine that promotes Th2 immune activity and supports antibody production, immune tolerance, and tissue repair. Produced by Th2 cells, mast cells, and basophils, IL-4 helps suppress excessive Th1-driven inflammation. Elevated IL-4 levels are often linked to allergies, asthma, eczema, and parasitic infections, reflecting Th2 dominance and increased antibody activity. Low IL-4 may occur in autoimmune or chronic inflammatory states, where regulatory immune signaling is reduced. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-4 serves as a key marker of anti-inflammatory balance, helping clinicians determine whether a patient’s immune system is tilted toward inflammatory (Th1/Th17) or regulatory (Th2) pathways.
IL-5 (Interleukin-5) is an anti-inflammatory Th2 cytokine that stimulates the production and activation of eosinophils, immune cells involved in allergic reactions, asthma, and defense against parasites. Produced by Th2 cells, mast cells, and ILC2s, IL-5 promotes antibody production and supports mucosal immunity. Elevated IL-5 levels are often seen in allergic diseases, asthma, and eosinophilic inflammation, indicating a Th2-dominant immune response. Low IL-5 may occur in Th1/Th17-driven inflammation or immune suppression, leading to reduced mucosal protection. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-5 serves as a marker of anti-inflammatory and Th2 activity, helping clinicians evaluate whether the immune system is balanced or skewed toward chronic inflammation or allergic hypersensitivity.
IL-6 (Interleukin-6) is a pro-inflammatory cytokine that plays a central role in inflammation, immune defense, and metabolic regulation. Produced by immune and tissue cells, IL-6 triggers the liver’s acute-phase response, supports antibody production, and influences energy metabolism. Elevated IL-6 levels indicate chronic inflammation and are associated with autoimmune disease, metabolic dysfunction, cardiovascular disease, and chronic infection. Persistently high IL-6 can also promote fatigue, tissue damage, and oxidative stress. Low IL-6 may reflect suppressed immune function or reduced inflammatory capacity. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-6 serves as a key marker of systemic inflammation and immune activation, helping clinicians identify chronic inflammatory drivers and guide strategies to restore immune balance.
IL-7 (Interleukin-7) is a cytokine essential for the development, maintenance, and survival of T and B lymphocytes, key players in the body’s adaptive immune system. Produced by stromal and epithelial cells in the bone marrow and thymus, IL-7 helps sustain immune cell balance and readiness. Elevated IL-7 levels often reflect immune activation, lymphocyte depletion, or chronic inflammation, as the body increases IL-7 production to replenish immune cells. High IL-7 can be seen in autoimmune diseases, chronic viral infections, and metabolic or inflammatory disorders, while low levels may indicate immune suppression or impaired bone marrow function. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-7 serves as a key marker of immune activity and adaptive resilience, helping clinicians assess whether the immune system is in a state of activation, recovery, or dysregulation.
IL-8 (Interleukin-8) is a pro-inflammatory chemokine that recruits neutrophils and other immune cells to sites of infection or tissue injury. Produced by immune and epithelial cells, IL-8 helps the body mount an effective inflammatory response, but when chronically elevated, it can contribute to autoimmune disease, metabolic inflammation, and tissue damage. High IL-8 levels are often linked to rheumatoid arthritis, IBD, asthma, chronic infections, and cardiometabolic disorders, reflecting sustained immune activation. Low IL-8 may occur with immune suppression or impaired inflammatory signaling. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-8 is a key indicator of innate immune activity and inflammatory load, helping clinicians identify chronic inflammatory or autoimmune processes and guide personalized strategies for restoring immune balance.
IRF measures young RBCs, indicating bone marrow activity and aiding anemia diagnosis.
Immature white blood cells.
Early infection inflammation marker
can be a useful marker of thrombopoietic activity.
Shows the youngest share of reticulocytes and early production changes.